Marimed Inc. splits its revenue into 7 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product Sales at $89.0 million, 56% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
164
|
160
|
158
|
149
|
134
|
121
|
51
|
46
|
12
|
6
|
4
|
| Product Sales |
—
|
89
-2.5%
share 55.7%
|
91
-4.4%
share 57.9%
|
96
+2.9%
share 64.3%
|
93
+13.0%
share 69.3%
|
82
+183.4%
share 67.6%
|
29
share 56.9%
|
—
|
—
|
—
|
—
|
| Product Sales Wholesale |
—
|
70
+10.6%
share 43.5%
|
63
+28.9%
share 39.9%
|
49
+48.4%
share 32.8%
|
33
+25.8%
share 24.5%
|
26
+150.7%
share 21.5%
|
10
share 20.5%
|
—
|
—
|
—
|
—
|
| Real Estate |
—
|
—
|
—
|
—
|
—
|
—
|
7
share 13.3%
|
—
|
—
|
—
|
—
|
| Supply Procurement |
—
|
—
|
—
|
2
-54.2%
share 1.0%
|
3
+59.1%
share 2.5%
|
2
share 1.7%
|
—
|
—
|
—
|
—
|
—
|
| Other |
—
|
1
-65.4%
share 0.8%
|
4
-17.6%
share 2.2%
|
4
-48.3%
share 2.9%
|
8
+2724162.3%
share 6.2%
|
0
-74.2%
share 0.0%
|
0
share 0.0%
|
—
|
—
|
—
|
—
|
| Management Service |
—
|
—
|
—
|
1
-16.2%
share 0.5%
|
1
-72.5%
share 0.6%
|
3
share 2.5%
|
—
|
—
|
—
|
—
|
—
|
| License And Service |
—
|
—
|
—
|
0
-55.2%
share 0.2%
|
1
-60.7%
share 0.4%
|
1
-12.0%
share 1.2%
|
2
share 3.3%
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- MRMD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Norwood, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1522767
- Former names
- WORLDS ONLINE INC. (until May 15, 2017)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.